Participated in Nervonik's oversubscribed $52.5M Series B for peripheral nerve stimulation, led by Amzak Health.
Nervonik is a clinical-stage bioelectronic medicine innovator developing a smart neuromodulation platform for peripheral nerve stimulation therapy that adjusts based on real-time physiological feedback
Nervonik is a clinical-stage bioelectronic medicine innovator developing a smart neuromodulation platform for peripheral nerve stimulation therapy that adjusts based on real-time physiological feedback.